Enter to win every day in CTNOW's 21 Days of Summer Giveaways. Click here to see today's prize.
Topics

Princeton University

Pfizer Expanding And Developing Its Vaccine Portfolio

Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems, company officials said Tuesday during a media briefing. The biggest U.S. drugmaker sells the world's top-selling vaccine, Prevnar 13 against pneumonia and other infections. The shot had sales of nearly $4.5 billion last year. New York-based Pfizer Inc. has long talked of building its portfolio in vaccines, one of its core research areas, but until last year Pfizer had no others. Now it has four approved in the U.S. and other countries. It's...

Loading
74°